<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02415647</url>
  </required_header>
  <id_info>
    <org_study_id>543389-8</org_study_id>
    <secondary_id>R01MH101519-01A1</secondary_id>
    <nct_id>NCT02415647</nct_id>
  </id_info>
  <brief_title>Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria</brief_title>
  <official_title>Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Upstate Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>State University of New York - Upstate Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to study new ways of classifying mental disorders in children
      based on observable behavior and genetics to ultimately diagnose these disorders better.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The NIMH Research Domain Criteria (RDoC) initiative seeks to further a long-range goal of
      contributing to diagnostic systems as informed by research on genetics, neuroscience, and
      behavior. The RDoC approach is based on identifying the most elemental units of analysis
      relevant to psychiatric disorders (such as genes and molecules) and using this matrix as a
      framework for investigation. In this case-control family study, the investigators will be
      using self-report questionnaires and computer-based tests to develop diagnostic methods for
      neuropsychiatric disorders in children, their siblings, and their parents. They will do this
      by recruiting &quot;normal&quot; and &quot;affected&quot; children, their siblings, and their parents. They will
      look at the subject, sibling, and parents to determine if psychiatric disorders are
      inherited. &quot;Affected&quot; children, ages 6-12, are those who have been diagnosed with a
      psychiatric disorder. Participants will undergo a battery of questionnaires/evaluations and a
      blood draw. The investigators will determine if the questionnaires and tests that reflect the
      constructs (such as reward prediction and willingness to work) predict psychopathology and
      impairment. The blood draw will be genotyped to determine if the measured constructs are
      associated with neuropsychiatric candidate genes, cross-disorder candidate gens and a
      cross-disorder polygenic score.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reward Valuation</measure>
    <time_frame>Baseline</time_frame>
    <description>Measures: Self-report, computerized tests, and DNA samples; Assessing correlations among family members and predictors of psychopathology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effort Valuation/Willingness to Work</measure>
    <time_frame>Baseline</time_frame>
    <description>Measures: Self-report, computerized tests, and DNA samples; Assessing correlations among family members and predictors of psychopathology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Expectancy/Reward Prediction Error</measure>
    <time_frame>Baseline</time_frame>
    <description>Measures: Self-report, computerized tests, and DNA samples; Assessing correlations among family members and predictors of psychopathology.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Initial Responsiveness to Reward Attainment</measure>
    <time_frame>Baseline</time_frame>
    <description>Measures: Self-report, computerized tests, and DNA samples; Assessing correlations among family members and predictors of psychopathology.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2800</enrollment>
  <condition>Mental Disorders</condition>
  <condition>Psychological Disorders</condition>
  <condition>Psychiatric, Diagnosis</condition>
  <condition>Mental Disorders Diagnosed in Childhood</condition>
  <arm_group>
    <arm_group_label>Child Proband with Psychiatric Disorder</arm_group_label>
    <description>Affected group of child probands with psychiatric disorders (ages 6-12 years).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Comparison Group</arm_group_label>
    <description>Non-disordered psychiatrically normal comparison group (ages 6-12 years).</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Child probands with psychiatric disorders will be recruited from psychiatric clinics, child
        psychiatrists, and mental health providers in Onondaga County. Non-disordered
        psychiatrially normal comparison groups will be recruited from a pediatric primary care
        clinic.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female, ages 6-12.

          -  biological child of parent(s) participating in testing.

        Exclusion Criteria:

          -  taking psychotropic medications.

          -  free of uncontrolled medical problems.

          -  major sensorimotor disability (e.g., deafness, blindness).

          -  diagnosed neurological condition.

          -  inadequate command of the English language.

          -  history of head injury with loss of consciousness lasting longer than 10 minutes.

          -  IQ estimated at below 80.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Faraone, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Upstate Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Van Orman, LMSW</last_name>
    <phone>315-464-3289</phone>
    <email>vanormas@upstate.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephen Glatt, Ph.D.</last_name>
    <phone>315-464-7742</phone>
    <email>glatts@upstate.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Van Orman, LMSW</last_name>
      <phone>315-464-3289</phone>
      <email>vanormas@upstate.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stephen Glatt, Ph.D.</last_name>
      <phone>315-464-7742</phone>
      <email>glatts@upstate.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Glatt, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Glatt SJ, Stone WS, Faraone SV, Seidman LJ, Tsuang MT. Psychopathology, personality traits and social development of young first-degree relatives of patients with schizophrenia. Br J Psychiatry. 2006 Oct;189:337-45.</citation>
    <PMID>17012657</PMID>
  </reference>
  <reference>
    <citation>Faraone SV, Seidman LJ, Kremen WS, Kennedy D, Makris N, Caviness VS, Goldstein J, Tsuang MT. Structural brain abnormalities among relatives of patients with schizophrenia: implications for linkage studies. Schizophr Res. 2003 Apr 1;60(2-3):125-40.</citation>
    <PMID>12591577</PMID>
  </reference>
  <reference>
    <citation>Faraone SV, Su J, Tsuang MT. A genome-wide scan of symptom dimensions in bipolar disorder pedigrees of adult probands. J Affect Disord. 2004 Oct;82 Suppl 1:S71-8.</citation>
    <PMID>15571792</PMID>
  </reference>
  <reference>
    <citation>Glatt SJ, Su JA, Zhu SC, Zhang R, Zhang B, Li J, Yuan X, Li J, Lyons MJ, Faraone SV, Tsuang MT. Genome-wide linkage analysis of heroin dependence in Han Chinese: results from wave one of a multi-stage study. Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):648-52.</citation>
    <PMID>16856125</PMID>
  </reference>
  <reference>
    <citation>Glatt SJ, Faraone SV, Lasky-Su JA, Kanazawa T, Hwu HG, Tsuang MT. Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Mol Psychiatry. 2009 Sep;14(9):885-93. doi: 10.1038/mp.2008.30. Epub 2008 Mar 11.</citation>
    <PMID>18332877</PMID>
  </reference>
  <reference>
    <citation>Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013 Apr 20;381(9875):1371-9. doi: 10.1016/S0140-6736(12)62129-1. Epub 2013 Feb 28. Erratum in: Lancet. 2013 Apr 20;381(9875):1360.</citation>
    <PMID>23453885</PMID>
  </reference>
  <reference>
    <citation>Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, Markel P, Lee H, Harkavy Friedman J, Kaufmann C, Cloninger CR, Tsuang MT. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet. 1998 Jul 10;81(4):290-5.</citation>
    <PMID>9674973</PMID>
  </reference>
  <reference>
    <citation>Faraone SV, Biederman J, Mick E, Wozniak J, Kiely K, Guite J, Ablon JS, Warburton R, Reed E. Attention deficit hyperactivity disorder in a multigenerational pedigree. Biol Psychiatry. 1996 May 15;39(10):906-8.</citation>
    <PMID>8860195</PMID>
  </reference>
  <reference>
    <citation>Faraone SV, Adamson JJ, Wilens TE, Monuteaux MC, Biederman J. Deriving phenotypes for molecular genetic studies of substance use disorders: a family study approach. Drug Alcohol Depend. 2007 May 11;88(2-3):244-50. Epub 2006 Dec 1.</citation>
    <PMID>17141426</PMID>
  </reference>
  <reference>
    <citation>Faraone SV, Adamson JJ, Wilens TE, Monuteaux MC, Biederman J. Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders. Drug Alcohol Depend. 2008 Jan 1;92(1-3):100-7. Epub 2007 Sep 4.</citation>
    <PMID>17766060</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2015</study_first_submitted>
  <study_first_submitted_qc>April 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2015</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>State University of New York - Upstate Medical University</investigator_affiliation>
    <investigator_full_name>Stephen V. Faraone</investigator_full_name>
    <investigator_title>Faculty</investigator_title>
  </responsible_party>
  <keyword>children</keyword>
  <keyword>mental health</keyword>
  <keyword>family genetic study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Neurodevelopmental Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

